|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
37
|
|
pubmed:dateCreated |
2006-9-29
|
|
pubmed:abstractText |
To evaluate the potential association of xeroderma pigmentosum group D (XPD) codon 751 variant with outcome after chemo-radiotherapy in patients with resected gastric cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1007-9327
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
7
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
6032-6
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17009404-Adult,
pubmed-meshheading:17009404-Aged,
pubmed-meshheading:17009404-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17009404-Codon,
pubmed-meshheading:17009404-Combined Modality Therapy,
pubmed-meshheading:17009404-Female,
pubmed-meshheading:17009404-Fluorouracil,
pubmed-meshheading:17009404-Humans,
pubmed-meshheading:17009404-Leucovorin,
pubmed-meshheading:17009404-Male,
pubmed-meshheading:17009404-Middle Aged,
pubmed-meshheading:17009404-Polymorphism, Genetic,
pubmed-meshheading:17009404-Predictive Value of Tests,
pubmed-meshheading:17009404-Prognosis,
pubmed-meshheading:17009404-Proportional Hazards Models,
pubmed-meshheading:17009404-Stomach,
pubmed-meshheading:17009404-Stomach Neoplasms,
pubmed-meshheading:17009404-Treatment Outcome,
pubmed-meshheading:17009404-Xeroderma Pigmentosum Group D Protein
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Xeroderma pigmentosum group D 751 polymorphism as a predictive factor in resected gastric cancer treated with chemo-radiotherapy.
|
|
pubmed:affiliation |
Laboratory of Biotechnology and Pharmacogenomics, University Clinic of Navarra, Pamplona 31008, Spain. rzarate@unav.es
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|
